Atlas Trials

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study

Clinical trial NCT04473274 · COMPLETED

Trial details

NCT number
NCT04473274
Sponsor
Samaritan Health Services
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronavirus InfectionDiabetes
Start date
2020-05-21
Primary completion
2020-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.